Randomized, double-blind study of emtricitabine (FTC) plus clevudine versus FTC alone in treatment of chronic hepatitis B

by Lim, S.G., Krastev, Z., Ng, T.M., Mechkov, G., Kotzev, I.A., Chan, S., Mondou, E., Snow, A., Sorbel, J., Rousseau, F.
Published 2011

Clinical trial: A phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B

by Lim, S.G., Leung, N., Hann, H.W.L., Lau, G.K.K., Trepo, C., Mommeja-Marin, H., Moxham, C., Sorbel, J., Snow, A., Blum, M.R., Rousseau, F., Marcellin, P.
Published 2011

A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B

by Lim, S.G., Ng, T.M., Guan, R., Kung, N., Krastev, Z., Volfova, M., Husa, P., Lee, S.S., Chan, S., Shiffman, M.L., Washington, M.K., Rigney, A., Anderson, J., Mondou, E., Snow, A., Sorbel, J., Rousseau, F.
Published 2011